NR1I2 and inflammatory bowel disease: PXR levels correlate well with intracellular bile acid levels in the gut and liver, and inhibiting PXR increases IL-8 and TNF-α and decreases IL-10 and TGF-β, suggesting a worsening of IBD symptoms.